Channel Infusion Pumps

Channel Infusion Pumps Market Outlook

The global Channel Infusion Pumps Market is projected to reach USD 5.60 billion by 2035, growing at a compound annual growth rate (CAGR) of approximately 7.5% from 2025 to 2035. This growth is primarily driven by the increasing prevalence of chronic diseases, which necessitate effective and continuous medication delivery systems. Additionally, advancements in healthcare technology and the rising adoption of smart infusion pumps equipped with safety features such as dose error reduction systems are significantly propelling the market forward. Moreover, the growing geriatric population that requires continuous medication makes infusion pumps an essential part of healthcare provision. The trend towards home healthcare services is also expected to bolster the demand for portable and user-friendly infusion devices, leading to a comprehensive growth trajectory for this market segment.

Growth Factor of the Market

The Channel Infusion Pumps Market is experiencing robust growth due to several key factors. Firstly, the increase in the incidence of chronic illnesses such as diabetes, cancer, and cardiovascular diseases is driving the need for precise medication delivery systems. Patients with these conditions often require continuous administration of drugs, making infusion pumps crucial for effective treatment. Secondly, technological advancements such as the integration of artificial intelligence and smart technologies into infusion systems are enhancing the efficiency and safety of these devices. Furthermore, the rising focus on patient-centric care and the push for reducing hospital stays are encouraging the adoption of home healthcare solutions, including portable infusion pumps. Additionally, ongoing research and development efforts aimed at improving pump safety and usability are likely to foster market growth. Lastly, the aging population is becoming increasingly significant, as older adults are more likely to require complex medication regimens, thereby further augmenting the demand for advanced infusion pumps.

Key Highlights of the Market

• The market is expected to grow at a CAGR of 7.5% from 2025 to 2035.
• North America holds the largest market share due to advanced healthcare infrastructure.
• Technological advancements, including smart infusion pumps, are enhancing market growth.
• Increased prevalence of chronic diseases is a primary growth driver.
• Home healthcare is emerging as a significant segment for infusion pump utilization.

By Product Type

Large Volume Infusion Pumps:

Large Volume Infusion Pumps are designed to deliver significant volumes of fluids, making them ideal for critical care environments. These pumps are widely used in hospitals for a range of applications, including fluid resuscitation, pain management, and medication delivery in intensive care units. Their ability to administer large quantities of fluids enables healthcare providers to effectively manage a patient's hydration levels and drug therapy, mitigating the risks associated with inadequate medication delivery. The increasing complexity of patient treatments and the demand for accurate volume delivery are driving the adoption of these pumps, especially with the rise in surgical procedures and critical care admissions.

Syringe Infusion Pumps:

Syringe Infusion Pumps are designed for precise delivery of small volumes of medication, making them particularly useful in pediatric and neonatal care settings. These pumps utilize a syringe to deliver medications at controlled rates, thus ensuring that patients receive accurate dosages. The demand for syringe infusion pumps is primarily driven by the need for precision in drug delivery, especially in sensitive patient populations. Their compact size and portability further enhance their utility, allowing for use in both hospital and home healthcare settings. Moreover, the integration of features such as dose error reduction systems is elevating the safety profile of these devices, fostering their adoption in various healthcare settings.

Ambulatory Infusion Pumps:

Ambulatory Infusion Pumps are portable devices designed to deliver medication to patients outside of traditional healthcare settings. These pumps are commonly used for outpatient therapies, such as chemotherapy and pain management, allowing patients to maintain their quality of life while receiving treatment. The growing trend toward outpatient care and home healthcare services is significantly boosting the demand for ambulatory infusion pumps. Their compact design and user-friendly interfaces make them suitable for use in various environments, including patients' homes. Additionally, advancements in battery technology and wireless connectivity are enhancing the functionality and appeal of these pumps, further supporting their market growth.

Implantable Infusion Pumps:

Implantable Infusion Pumps are devices surgically placed within a patient's body to provide medication delivery over extended periods. These pumps are particularly useful for chronic conditions requiring continuous medication, such as chronic pain management and insulin delivery for diabetes. The increasing prevalence of chronic diseases along with advancements in materials and technology are driving the market for implantable infusion pumps. Their ability to provide consistent and long-term therapy without the need for frequent manual intervention makes them appealing to both patients and healthcare providers. Furthermore, the reduced risk of infection and complications associated with these devices is significantly contributing to their acceptance in clinical practice.

Enteral Infusion Pumps:

Enteral Infusion Pumps are specialized devices used to deliver nutrition directly to the stomach or intestines of patients who cannot ingest food orally. These pumps are particularly vital in the management of patients with swallowing difficulties, neurological disorders, or severe illness. The increasing awareness about the importance of nutrition in patient recovery is driving the adoption of enteral infusion pumps. Healthcare facilities are increasingly investing in these pumps to provide enteral feeding safely and effectively, which is crucial for patient outcomes. Additionally, the growing prevalence of conditions that necessitate enteral feeding, such as cancer and gastrointestinal disorders, is further fueling the demand for these devices.

By Application

Chemotherapy:

Chemotherapy is one of the prominent applications of infusion pumps, particularly due to the increasing incidence of cancer worldwide. Infusion pumps are essential for delivering chemotherapy drugs with precision, allowing for controlled dosing and minimizing the risk of side effects. The adoption of smart infusion pumps equipped with dose error reduction systems is enhancing safety and efficacy in chemotherapy administration. As cancer prevalence continues to rise and treatment modalities become more complex, the demand for reliable chemotherapy infusion pumps is expected to grow significantly, supporting overall market expansion.

Diabetes:

Insulin infusion pumps are becoming increasingly popular for diabetes management, providing patients with a consistent and controlled method of insulin delivery. These devices allow for precise dosing adjustments based on real-time glucose levels, improving patient outcomes and quality of life. The rising prevalence of diabetes globally, along with a growing focus on personalized medicine, is driving the demand for insulin infusion pumps. Additionally, advancements in technology, such as integration with continuous glucose monitoring systems, are further enhancing the effectiveness of these devices, making them critical tools in diabetes care.

Gastroenterology:

Infusion pumps play a significant role in gastroenterology, particularly for patients requiring enteral feeding or specific drug therapies for gastrointestinal disorders. These pumps allow for the controlled and precise delivery of nutrition or medications, making them essential in managing conditions such as inflammatory bowel disease and other chronic gastrointestinal issues. With the rising awareness of the importance of nutritional support in the management of gastrointestinal diseases, the demand for enteral infusion pumps is anticipated to increase. Furthermore, the integration of feeding protocols and safety features in these devices is enhancing their adoption in clinical settings.

Analgesia/Pain Management:

Infusion pumps are widely employed in analgesia and pain management, particularly for patients experiencing severe pain post-operatively or those suffering from chronic pain conditions. These devices allow for continuous or on-demand delivery of analgesics, providing effective pain relief while minimizing the need for frequent manual administration. The increasing prevalence of chronic pain conditions and the rising number of surgical procedures are driving the demand for analgesia infusion pumps. Moreover, advancements in technology that enhance the safety and user-friendliness of these devices are further propelling market growth, ensuring that patients receive adequate pain management.

Pediatrics:

The pediatric application of infusion pumps is gaining traction due to the unique needs of children requiring precise medication delivery. Pediatric patients often have different pharmacokinetic profiles compared to adults, necessitating specialized infusion systems that can cater to their specific requirements. The rising incidence of chronic diseases among children, including diabetes and various types of cancer, is driving the adoption of infusion pumps tailored for pediatric use. Additionally, innovations aimed at enhancing the safety and ease of use of these pumps in pediatric settings are boosting their acceptance among healthcare providers and families alike.

By Distribution Channel

Hospitals:

The hospital segment represents a significant portion of the Channel Infusion Pumps Market, as these facilities frequently utilize infusion pumps for a myriad of inpatient treatments. Hospitals invest heavily in advanced medical devices to ensure patient safety and effective treatment outcomes. The increasing number of surgical procedures and admissions for chronic conditions is driving the demand for infusion pumps in hospital settings. Furthermore, the integration of smart technologies in infusion devices within hospitals is enhancing their efficacy, leading to better patient management and reduced medication errors, thus fostering further growth in this segment.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are becoming increasingly important in the distribution of infusion pumps, particularly for outpatient procedures. These facilities often require efficient and effective infusion systems to manage patient care post-surgery and during outpatient treatments. The trend toward outpatient care is driving the demand for portable and user-friendly infusion pumps that can be easily managed by patients and caregivers. Additionally, the growing focus on reducing healthcare costs and improving patient outcomes in ASCs is contributing to the rising adoption of infusion pumps in these facilities.

Specialty Clinics:

Specialty clinics play a pivotal role in the Channel Infusion Pumps Market, particularly in fields such as oncology, diabetes management, and pain management. These clinics often utilize infusion pumps for targeted therapies, ensuring that patients receive accurate dosages of medications specific to their conditions. The increasing prevalence of chronic diseases and the growing demand for specialized care are driving the adoption of infusion pumps in these settings. Furthermore, the rise in patient referrals to specialty clinics for complex treatment regimens is expected to bolster the market for infusion pumps in this segment significantly.

Home Healthcare:

The home healthcare segment is rapidly expanding, driven by the trend towards patient-centric care and the desire to minimize hospital stays. Infusion pumps designed for home use are becoming essential tools for patients requiring long-term medication administration, such as those undergoing chemotherapy or managing diabetes. The convenience and comfort of receiving treatment at home are appealing to patients and caregivers, leading to increased adoption of portable infusion pumps. Moreover, advancements in technology that enhance the usability and safety of home infusion devices are further supporting market growth in this segment.

Online Retailers:

The growth of e-commerce has significantly impacted the distribution of infusion pumps, particularly as more healthcare providers and patients turn to online platforms for purchasing medical devices. Online retailers provide an extensive selection of infusion pumps, often at competitive prices, making them accessible to a broader audience. The convenience of online shopping, coupled with the growing trend towards home healthcare, is driving the demand for infusion pumps through digital channels. Additionally, online retailers often provide additional resources and support for patients and caregivers, facilitating the adoption of infusion devices in home care settings.

By Ingredient Type

Insulin:

Insulin is a crucial ingredient in the treatment of diabetes, and infusion pumps specifically designed for insulin delivery are becoming increasingly prevalent. These pumps allow for continuous or on-demand insulin administration, providing patients with the flexibility to manage their blood glucose levels effectively. The rise in diabetes prevalence, coupled with the growing focus on personalized medicine, is driving the demand for insulin infusion pumps. Moreover, technological advancements, such as the integration of continuous glucose monitoring systems with insulin pumps, are enhancing the effectiveness of these devices, further supporting market growth.

Chemotherapy Drugs:

Chemotherapy drugs are vital in the treatment of various cancers, and infusion pumps play a critical role in delivering these medications safely and effectively. The need for precise dosing and continuous administration of chemotherapy agents makes infusion pumps indispensable in oncology settings. The growing incidence of cancer worldwide is driving the demand for chemotherapy infusion pumps, as healthcare facilities seek to provide optimal treatment for their patients. Furthermore, innovations in chemotherapy infusion systems aimed at improving safety and minimizing side effects are contributing to market growth in this segment.

Antibiotics:

Antibiotics are commonly administered via infusion pumps in various healthcare settings, particularly for patients with severe infections requiring intravenous therapy. Infusion pumps enable healthcare providers to deliver precise dosages of antibiotics, ensuring effective treatment while minimizing the risk of adverse effects. The rising incidence of antibiotic-resistant infections and the growing focus on effective infection management are driving the demand for infusion pumps designed for antibiotic delivery. Additionally, advancements in infusion technologies that enhance the safety and reliability of antibiotic administration are further bolstering this segment of the market.

Analgesics:

Analgesics are widely used in pain management, and infusion pumps are essential devices for delivering these medications. Continuous or on-demand delivery of analgesics via infusion pumps allows for effective pain control, particularly in post-surgical settings or for patients with chronic pain conditions. The increasing prevalence of pain-related disorders and the growing focus on patient-centered pain management solutions are driving the demand for analgesic infusion pumps. Furthermore, the development of advanced infusion systems with improved safety features is enhancing the appeal of these devices for managing pain effectively.

Immunoglobulins:

Immunoglobulins are critical components of the immune system, and infusion pumps are frequently used to administer these substances for various therapeutic purposes. Patients with immunodeficiency disorders often require regular immunoglobulin therapy, making infusion pumps essential for delivering consistent and effective treatment. The rising incidence of immunodeficiency disorders and the growing recognition of the importance of immunoglobulin therapy in managing these conditions are driving market demand. Additionally, advancements in infusion technology that enhance patient safety and comfort during immunoglobulin administration are further supporting growth in this segment.

By Region

The Channel Infusion Pumps Market exhibits varied growth patterns across different regions, with North America holding the largest market share, primarily due to its advanced healthcare infrastructure and high adoption of advanced medical technologies. The market in North America is expected to grow at a CAGR of 7.8% from 2025 to 2035, driven by the increasing prevalence of chronic diseases and the need for effective medication delivery systems. The presence of key players and ongoing innovations in infusion technology are further bolstering market growth in this region. Additionally, the rising geriatric population is significantly contributing to the demand for infusion pumps, as elderly patients often require chronic disease management.

Europe is also witnessing substantial growth in the Channel Infusion Pumps Market, fueled by the increasing focus on patient safety and the adoption of smart infusion systems. The growing awareness of home healthcare solutions and the necessity for efficient medication delivery in outpatient settings are driving market expansion in this region. Similarly, the Asia Pacific region is expected to experience rapid growth due to increasing investments in healthcare infrastructure, rising awareness regarding chronic diseases, and growing patient populations that necessitate infusion therapy. The Latin America and Middle East & Africa regions are gradually catching up, driven by improving healthcare facilities and rising disposable incomes that enable better access to advanced medical devices.

Opportunities

The Channel Infusion Pumps Market presents numerous opportunities, particularly in the realm of technological advancements. With the ongoing development of smart infusion pumps integrated with wireless connectivity and artificial intelligence, healthcare providers can enhance patient safety and streamline medication administration processes. These innovations not only improve the accuracy of drug delivery but also facilitate remote monitoring and data collection, allowing healthcare professionals to make more informed decisions regarding patient care. Furthermore, as telehealth services gain traction, the demand for home healthcare solutions, including portable infusion pumps, is set to increase significantly, presenting a lucrative opportunity for market players to develop more advanced and user-friendly devices.

Another notable opportunity lies in the expansion of healthcare access in emerging markets. As countries in Asia Pacific, Latin America, and Africa continue to invest in healthcare infrastructure, the demand for medical devices such as infusion pumps will rise. The increasing prevalence of chronic diseases in these regions necessitates effective and efficient medication delivery systems. Companies that can establish a strong presence in these emerging markets by providing affordable, high-quality infusion pumps and comprehensive support services will be well-positioned to capitalize on this growing demand, ultimately driving market growth.

Threats

Despite the promising growth prospects, the Channel Infusion Pumps Market faces several threats that could hinder progress. One major concern is the stringent regulatory environment governing medical devices, which can result in lengthy approval processes and increased costs for manufacturers. Compliance with regulatory standards is crucial for ensuring patient safety, but it can also limit the speed at which new technologies are introduced to the market. Moreover, the potential for product recalls and liabilities due to malfunctioning devices poses a significant threat to companies operating in this space, as negative publicity can damage brand reputation and erode consumer trust.

Additionally, the rapid pace of technological advancements in the medical device industry creates a highly competitive landscape. New entrants and established players continuously innovate to capture market share, leading to price competition that can squeeze profit margins. Companies that fail to keep up with evolving technologies or meet changing patient needs risk losing their competitive edge. Furthermore, the ongoing global economic uncertainties caused by events such as the COVID-19 pandemic may impact healthcare budgets, affecting investments in new medical technologies, including infusion pumps, and thereby posing a challenge to sustained market growth.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Medtronic plc
• Baxter International Inc.
• Fresenius Kabi AG
• Smiths Medical
• Terumo Corporation
• Moog Inc.
• ICU Medical, Inc.
• Zyno Medical, LLC
• Halyard Health, Inc.
• Hospira, Inc. (a subsidiary of Pfizer Inc.)
• Alaris Medical Systems
• Grifols S.A.
• Vygon S.A.
• Medline Industries, Inc.

The competitive landscape of the Channel Infusion Pumps Market is characterized by the presence of several established players, each aiming to strengthen its market position through innovation, strategic partnerships, and geographic expansion. Major companies such as BD, Medtronic, and Baxter International are leading the market, offering a wide range of infusion pump solutions designed to meet diverse healthcare needs. These companies continually invest in research and development to enhance the functionality and safety of their devices, thereby maintaining their competitive advantage. Additionally, acquisitions and mergers among key players are common strategies to broaden product portfolios and enhance distribution channels, allowing for increased market penetration.

BD (Becton, Dickinson and Company) stands out as a market leader with a comprehensive range of infusion pumps equipped with advanced safety features. Their commitment to innovation has resulted in the development of smart infusion systems that reduce medication errors and improve patient outcomes. Similarly, Medtronic plc, known for its cutting-edge medical technology, offers a variety of infusion devices tailored for specific therapeutic areas. The company's focus on integrating connected health technologies into its infusion systems positions it well to capitalize on the growing demand for remote patient monitoring solutions.

Baxter International Inc. is another key player in the Channel Infusion Pumps Market, recognized for its dedication to patient safety and quality. The company's diverse product offerings include large volume infusion pumps and ambulatory infusion devices that cater to a wide range of clinical needs. Baxter's focus on enhancing the user experience and ensuring compliance with regulatory standards has solidified its reputation as a trusted provider in the infusion pump market. The continuous expansion of Baxter’s product lines, coupled with its strategic partnerships, enables the company to maintain a strong foothold in the market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Moog Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Vygon S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Grifols S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smiths Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fresenius Kabi AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 ICU Medical, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Zyno Medical, LLC
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Terumo Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Halyard Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Alaris Medical Systems
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Medline Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Baxter International Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Hospira, Inc. (a subsidiary of Pfizer Inc.)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Channel Infusion Pumps Market, By Application
    • 6.1.1 Chemotherapy
    • 6.1.2 Diabetes
    • 6.1.3 Gastroenterology
    • 6.1.4 Analgesia/Pain Management
    • 6.1.5 Pediatrics
  • 6.2 Channel Infusion Pumps Market, By Product Type
    • 6.2.1 Large Volume Infusion Pumps
    • 6.2.2 Syringe Infusion Pumps
    • 6.2.3 Ambulatory Infusion Pumps
    • 6.2.4 Implantable Infusion Pumps
    • 6.2.5 Enteral Infusion Pumps
  • 6.3 Channel Infusion Pumps Market, By Ingredient Type
    • 6.3.1 Insulin
    • 6.3.2 Chemotherapy Drugs
    • 6.3.3 Antibiotics
    • 6.3.4 Analgesics
    • 6.3.5 Immunoglobulins
  • 6.4 Channel Infusion Pumps Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Home Healthcare
    • 6.4.5 Online Retailers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Channel Infusion Pumps Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Channel Infusion Pumps market is categorized based on

By Product Type

• Large Volume Infusion Pumps
• Syringe Infusion Pumps
• Ambulatory Infusion Pumps
• Implantable Infusion Pumps
• Enteral Infusion Pumps

By Application

• Chemotherapy
• Diabetes
• Gastroenterology
• Analgesia/Pain Management
• Pediatrics

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Home Healthcare
• Online Retailers

By Ingredient Type

• Insulin
• Chemotherapy Drugs
• Antibiotics
• Analgesics
• Immunoglobulins

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Medtronic plc
• Baxter International Inc.
• Fresenius Kabi AG
• Smiths Medical
• Terumo Corporation
• Moog Inc.
• ICU Medical, Inc.
• Zyno Medical, LLC
• Halyard Health, Inc.
• Hospira, Inc. (a subsidiary of Pfizer Inc.)
• Alaris Medical Systems
• Grifols S.A.
• Vygon S.A.
• Medline Industries, Inc.